90660096 - MYRIAD GENETICS

Information

• Trademark
• 90660096

• Source

• Serial Number

  90660096

• Registration Number

  7133864

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 21, 2021
  3 years ago

• Registration Date

  August 08, 2023
  a year ago

• Transaction Date

  July 09, 2024
  7 months ago

• Status Date

  August 08, 2023
  a year ago

• Published for Opposition Date

  November 30, 2021
  3 years ago

• Location Date

  July 03, 2023
  a year ago

• First Use Anywhere Date

  May 04, 2021
  3 years ago

• First Use In Commerce Date

  May 04, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  DE JONGE, KATHLEEN RUS

• Attorney Docket Number

  131588-1165

  Attorney Name

  Katherine P. Califa

  Law Office Assigned Location Code

  L70

• Owners

  • Myriad Genetics, Inc.

Case File Statements

• DM0000: The mark consists of the word "MYRIAD" with the "M" appearing as a capital letter formed by four (4) lines that do not touch, and the remainder of the word appearing in lowercase letters, and the word "GENETICS" directly below "MYRIAD" appearing in lowercase letters.
• GS0441: Genetic testing services for diagnostic or treatment purposes; genetic testing for medical purposes; genetic counseling; diagnostic services in the field of genetics, namely, the identification of genes that predispose individuals to common diseases and health disorders for diagnostic or treatment purposes; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing, monitoring, and reporting services; internet-based health care information services; providing an internet website for medical professionals featuring medical information in the field of hereditary cancer risk assessment and testing; providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment, drug, and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis and medical and pharmaceutical consultation services related thereto, namely, discussion and interpretation with clients of medical test results and medical analysis related thereto; medical testing services, namely, providing medical tests that measure, analyze, and interpret genes and medications of patients, environmental, and other factors through an algorithm that weighs the contribution of each medication's multiple pathways of absorption, distribution, metabolism, and excretion and each medication's receptor activity, mechanism of action, and pathways of response and then measures the impact of genomic changes across these pathways and across multiple of patients to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection, and treatment options and choices for patients, identify potentially harmful drug interactions, and calculate drug dosage adjustments for patients; and medical information services, namely, preparation and generation of reports for the foregoing medical testing services through proprietary software applications; medical analysis and consultation services which use bioinformatics for diagnostic or treatment purposes; providing objective, evidence-based medical information tailored to each patient's individual genetic profile to enable clinicians to prescribe individually appropriate medications
• DS0000: "GENETICS"
• GS0421: Clinical research in the field of genetics directed to the evaluation of genetic variants; clinical research in human genetics; statistical analysis relating to scientific research in the field of human genetics and genetic variation; design and development of statistical algorithms for use in the field of human genetics and evaluation of genetic variations; statistical analysis for determining deleterious genetic variations in the field of human genetics, for scientific research purposes; clinical trial research and laboratory research services for the further purpose of drug discovery services, pharmaceutical research services, pre-clinical medical research screening, and clinical trial, research and evaluation services; biosignatures, genomics, proteomics and pharmacology research services; development of disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening for scientific research purposes, pre-clinical research and trials for pharmaceutical development purposes; and research and development of new diagnostic products and pharmaceutical drug services for others; biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs, and the environment; providing temporary use of non-downloadable computer software for customizing, selecting, and ordering health and genetic analysis and diagnostic kits and assays and for accessing, viewing, and storing health and genetic information via electronic, optical, and wireless communication networks; scientific research analysis and consulting services which use bioinformatics; gene and tissue bank services that provide DNA samples for use in future medical and scientific research, medical and scientific educational studies and development of new medical and scientific products and validation thereof

Case File Event Statements

• 4/24/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/28/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/6/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/29/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 9/8/2021 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/8/2021 - 3 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/8/2021 - 3 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/25/2021 - 3 years ago

  8 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/25/2021 - 3 years ago

  9 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/25/2021 - 3 years ago

  10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/25/2021 - 3 years ago

  11 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/25/2021 - 3 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/10/2021 - 3 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/30/2021 - 3 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/30/2021 - 3 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/25/2022 - 3 years ago

  16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/27/2022 - 3 years ago

  17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/27/2022 - 3 years ago

  18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/27/2022 - 3 years ago

  19 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 1/27/2022 - 3 years ago

  20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/17/2022 - 2 years ago

  21 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 6/17/2022 - 2 years ago

  22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/17/2022 - 2 years ago

  23 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/17/2022 - 2 years ago

  24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/17/2022 - 2 years ago

  25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 7/25/2022 - 2 years ago

  26 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/25/2022 - 2 years ago

  27 - SOU EXTENSION 1 FILED Type: EXT1

• 7/25/2022 - 2 years ago

  28 - SOU EXTENSION 1 GRANTED Type: EX1G

• 7/27/2022 - 2 years ago

  29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/15/2022 - 2 years ago

  30 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/15/2022 - 2 years ago

  31 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 12/15/2022 - 2 years ago

  33 - SOU EXTENSION 2 FILED Type: EXT2

• 12/15/2022 - 2 years ago

  35 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 1/25/2023 - 2 years ago

  32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/3/2023 - 2 years ago

  34 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/3/2023 - 2 years ago

  36 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 2/4/2023 - 2 years ago

  37 - CORRECTED NOA E-MAILED Type: NOAC

• 2/4/2023 - 2 years ago

  38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/27/2023 - a year ago

  39 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 6/27/2023 - a year ago

  40 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/27/2023 - a year ago

  41 - SOU EXTENSION 3 FILED Type: EXT3

• 6/27/2023 - a year ago

  43 - USE AMENDMENT FILED Type: IUAF

• 6/30/2023 - a year ago

  42 - SOU EXTENSION 3 GRANTED Type: EX3G

• 6/30/2023 - a year ago

  44 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 7/1/2023 - a year ago

  45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/3/2023 - a year ago

  46 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 7/4/2023 - a year ago

  47 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 7/26/2023 - a year ago

  48 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 8/8/2023 - a year ago

  49 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/8/2023 - a year ago

  50 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/9/2024 - 7 months ago

  51 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/9/2024 - 7 months ago

  53 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/9/2024 - 7 months ago

  52 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 7/9/2024 - 7 months ago

  54 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/9/2024 - 7 months ago

  55 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA